Bcl‐2 family: Life‐or‐death switch

By Y. Tsujimoto, S. Shimizu. FEBS Letters, 2000

703 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Copper complexes as anticancer agents. (2009, background): “[103] have modified the structure of nimesulide (25), a well-known cyclooxygenase-2 (COX-2) inhibitor [104,105], with pharmacophores capable of targeting vascular endothelial growth factor (VEGF) [106,107] and anti-apoptotic proteins like Bcl-2 and Bcl-XL, besides targeting the COX enzymes [108-111]”
Calcium, ATP, and ROS: a mitochondrial love-hate triangle. (2004, background): “0363-6143/04 $5.00 Copyright© 2004 the American Physiological Societyhttp://www.ajpcell.org C817 by 10.220.32.247 on O ctober 4, 2017 http://ajpcell.physiology.org/ D ow nloaded from Ca2 , recent studies suggest that the outer membrane voltagedependent anion channel (VDAC) is a ruthenium red (RuRed)”